Intent to Sole Source: Mozart 3-D Specimen Tomosynthesis System

The Joseph Maxwell Cleland Atlanta VA Medical Center intends to sole source a Mozart 3-D Specimen Tomosynthesis System from KUB Technologies to enhance breast cancer surgery outcomes by enabling 3D imaging of breast specimens following lumpectomies or excisions. This system, known as the Mozart iQ, uses 3D specimen tomosynthesis—the current standard of care—to produce detailed X-ray images that accurately locate tumors and surgical clips, overcoming limitations of traditional 2D imaging where dense tissue can obscure critical details. The acquisition is necessary because the facility currently lacks this capability, and the system will improve diagnostic precision and surgical outcomes for veteran patients. The solicitation number for this intent to sole source is 36C24726Q0725, posted on August 4, 2026, with responses due by August 6, 2026. The procurement falls under NAICS code 334517 for medical equipment manufacturing and is managed by the 247-NETWORK Contract Office 7 under the Department of Veterans Affairs, located in Augusta, Georgia. The place of performance is the Atlanta VA Medical Center in Atlanta, Georgia, with Monica A. Reed as the primary point of contact. No set-aside provisions apply, and the intent is to proceed with a single vendor due to the unique and proprietary nature of the Mozart iQ system, which is essential for maintaining clinical standards in breast cancer care.